| abstract |
Glycoconjugates, therapeutic compositions comprising glycoconjugates and methods of using glycoconjugates are disclosed. In particular, a peptide of aglyco 10B is provided that is recognized as an antigen by the immune system and is immune epitope reacted. This conjugate prevents the influenza virus from binding to cells and is useful for the treatment of schizophrenia and the diagnosis of chronic viral diseases associated with the development of cancer. |